Guidance on evaluation fees for human drugs and disinfectants: Overview

Guidance on evaluation fees for human drugs and disinfectants: Overview Health Canada has recently updated the Guidance document on fees for the review of human and disinfectant drug submissions and applications. The revised guidance takes effect on March 19, 2021. 2023-09-01 Health Canada open-ouvert@tbs-sct.gc.ca Health and Safetydrug submissions-and-applicationshuman-drugs-and-disinfectants submissionguidance-document on feesfees for reviewevaluation feesguidance-document overviewrevised guidance Guidance on evaluation fees for human drugs and disinfectants: OverviewHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/fees/fees-review-drug-submissions-applications.html Guidance on evaluation fees for human drugs and disinfectants: OverviewHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/frais/examen-presentations-demandes-drogue.html

Health Canada has recently updated the Guidance document on fees for the review of human and disinfectant drug submissions and applications. The revised guidance takes effect on March 19, 2021.

Data and Resources

Similar records